Saturday 17 October 2026 Export BIIB’s income statement to Excel — free account

Biogen Inc.

BIIB Healthcare Drug Manufacturers General

Biogen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.9 billion, up 2.22% from fiscal 2024. In the quarter to June 2026, revenue grew 3.42%, EPS fell 84.8%, free cash flow grew 103.3% and total debt rose 16.0%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.

232.65 2.70 −1.15%

Follow BIIB

Alert me

Market cap: $34.8B
P/E: 41.0×
Fwd P/E: 31.5×
Dividend yield: —
F-score: 4/9
Altman Z: 3.13
Beneish M: −2.67
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	4.58%	7.70%	7.39%	9.31%	+8 more TTM periods Free account
Piotroski F-Score Full definition →	3	4	4	5
ROA Full definition →	2.76%	4.77%	4.50%	5.59%
ROIC Full definition →	3.11%	5.69%	5.61%	6.71%
Return on Tangible Assets Full definition →	13.08%	14.90%	14.89%	18.44%
Average Days of Receivables Full definition →	68.63	50.29	49.54	49.83
Free Cash Flow per Share Full definition →	17.20	16.31	13.78	15.43
Free Cash Flow Full definition →	2,540.00	2,401.30	2,019.20	2,262.10
Capital Expenditures Full definition →	(338.80)	(189.50)	(185.40)	(191.50)
Other line items
Cash ROIC Full definition →	9.26%	8.22%	7.12%	7.95%
Accounts Receivable Turnover Full definition →	5.71	5.91	7.20	6.92
Accounts Payable Turnover Full definition →	6.42	6.50	5.62	5.96
Inventory Turnover Full definition →	1.12	1.15	1.04	1.07
Average Days of Payables Full definition →	56.53	53.72	65.59	60.50
Days of Inventory on Hand Full definition →	333.72	292.04	329.16	323.58
Tax Rate Full definition →	(0.17)	(0.15)	(0.17)	(0.16)
Research and Development Expense of Revenue Full definition →	20.08%	18.95%	17.98%	17.71%
Selling, General and Administrative Expense of Revenue Full definition →	25.87%	24.84%	24.61%	24.15%
Share Based Compensation of Revenue Full definition →	2.95%	2.96%	2.94%	3.04%
Operating CF/Net income Full definition →	3.45	1.89	1.71	1.53
Depreciation/Fixed assets Full definition →	0.45	0.38	0.35	0.31
Capex/Depreciation Full definition →	(0.25)	(0.16)	(0.17)	(0.20)
Revenue per Share Full definition →	67.89	67.51	67.51	68.66
Operating CF per Share Full definition →	19.49	17.60	15.05	16.74
Capex per Share Full definition →	(2.29)	(1.29)	(1.27)	(1.31)
Capex to Sales Full definition →	0.03	0.02	0.02	0.02

Show all line items

Columns are period end dates

Stockrow Weekly